One-Year Outcomes of Intravitreal Conbercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration. Ophthalmic Res. 2019;62(2):93‐100.
2021.03.31
Li X, Zhang Y, Zhang Z, Xu Y, Zhang M. One-Year Outcomes of Intravitreal Conbercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration. Ophthalmic Res. 2019;62(2):93‐100.